White House suggests COVID-19 vaccines effective against ‘lambda’ variant

Published July 6, 2021 6:11pm ET



The White House issued a vote of confidence Tuesday that the COVID-19 vaccines are effective against a new virus variant that has caused concern among health experts.

At issue is the so-called “lambda variant,” which the World Health Organization has called a “variant of interest” because it has mutated in a way that could make it more easily passed among humans and may not be nixed by the “neutralizing antibodies” inside the body that the vaccines produce.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.